Related Experiment Video

Updated: Jun 23, 2026

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions

Carl E Allen, Kenneth L McClain

    Nature Medicine
    |May 9, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
    07:43

    Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

    Published on: July 29, 2017

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
    12:59

    Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

    Published on: September 26, 2013

    Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
    07:43

    Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

    Published on: July 29, 2017

    Related Concept Videos

    T Cell Types and Functions01:24

    T Cell Types and Functions

    When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
    Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

    Articles linked to this work by shared authors, journal, and citation graph.

    Central Nervous System Involvement in Children with Hemophagocytic Lymphohistiocytosis: an HLH-2004 Study Report.

    Blood advances·2026

    Current Approaches Among Medical Providers Treating Pediatric Langerhans Cell Histiocytosis.

    Pediatric blood & cancer·2026

    Genome-wide association study identifies and validates genetic variation in the RIG-I/MAVS signaling pathway associated with HIV-related Kaposi sarcoma in children and adults.

    Frontiers in oncology·2026

    Clofarabine for relapsed/refractory LCH and non-LC histiocytosis.

    Blood advances·2026

    Disease extent, not lesion location, determines relapse risk in single-system skeletal Langerhans cell histiocytosis.

    Blood advances·2026

    Lenalidomide-Dexamethasone as an Effective and Well-Tolerated Treatment Option for Refractory Rosai-Dorfman-Destombes Disease: A Clinical and Pharmacophenomic Study.

    American journal of hematology·2026

    A health-system-scale, episode-resolved multimodal atlas of cancer cachexia.

    Nature medicine·2026

    Population-scale reconstruction of menopause dynamics reveals a physiological cliff at the final menstrual period.

    Nature medicine·2026

    AI-assisted scoping review of code sharing in clinical prediction model research.

    Nature medicine·2026

    An open vision-language model for diverse medical applications.

    Nature medicine·2026

    Extended follow-up of in vivo BCMA CAR-T therapy in relapsed/refractory multiple myeloma.

    Nature medicine·2026

    Oral small-molecule GLP-1RA safiglipron versus dapagliflozin in type 2 diabetes: a randomized, double-blind, active-comparator-controlled phase 3 trial.

    Nature medicine·2026

    Case Report: Efgartigimod in refractory non-tumor Lambert-Eaton myasthenic syndrome.

    Frontiers in immunology·2026

    Thymic CT attenuation score in SAPHO syndrome: a comparative study with rheumatoid arthritis, ankylosing spondylitis, and healthy controls.

    Frontiers in immunology·2026

    Circulating angiogenic T cells as potential immune-vascular biomarkers associated with disease activity in axial spondyloarthritis.

    Frontiers in immunology·2026

    Immune profiling of anti-SSA-positive at-risk individuals reveals increased type I IFN activity preceding lymphocyte abnormalities in Sjögren's disease.

    Frontiers in immunology·2026

    Case Report: IgG4-related lung disease.

    Frontiers in immunology·2026

    Anti-GBM disease shortly after clinically presumed ANCA-associated vasculitis in an 85-year-old patient: a case report and literature review.

    Frontiers in nephrology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us